GenapSys: Accelerate your research with an accurate & affordable benchtop DNA sequencing platform, powered by electrical detection. Learn more about the GenapSys system.
Social Links
What is GenapSys's Revenue?
GenapSys's estimated revenue for 2023 is $6M.
What does GenapSys do?
At GenapSys we are working to power the world of healthcare and diagnostics with advanced DNA sequencing technology. Our sequencing instrument platform leverages a proprietary electrical microfluidic sequencing chip with a scalable number of detectors, enabling a wide range of applications including targeted sequencing in oncology, pharmacogenomics and genome-wide sequencing in microbiology and others. We believe in a world where every researcher has a compact, scalable, and affordable sequencer in their own lab, empowering the democratization of genetic sequencing. Our novel sequencing method is revolutionizing genomics discovery, biomedical research, healthcare, diagnostics, agriculture, and a variety of other fields.
Our team brings together an incredibly diverse and multidisciplinary set of backgrounds and skills – from electrical and mechanical engineers, physicists, chemists, microfluidic engineers, molecular biologists, bioinformaticians, mathematicians and more. It is a super exciting time to join GenapSys as we recently launched our first product which is generating a tremendous amount of interest.
Sorry we could not load this information
You May Also Find These Company Reviews Interesting
Goldbelly is a curated marketplace for gourmet food & food gifts. we feature america’s most legendary and iconic foods and gifts that you can order directly to your door.... More
Replicon's free time tracking software provides an all-in-one solution for project time tracking, time attendance and professional services automation. know more!... More
Brightpearl is a retail operating system (ros) for retailers and wholesalers that’s built for hyper scalability. brightpearl automates the back office so merchants can get back time and grow fearlessly.... More